TMEPAI Antibody (rPMEPA1/6422) [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08259R
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry-Paraffin
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # rPMEPA1/6422
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant full-length human TMEPAI protein (Uniprot: Q96W9 )
Localization
Cell surface, Cytoplasm
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for TMEPAI Antibody (rPMEPA1/6422) [DyLight 550]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TMEPAI
Alternate Names
prostate transmembrane protein, androgen induced 1, Solid tumor-associated 1 protein, STAG1prostate androgen induced RNA, transmembrane prostate androgen-induced protein
Gene Symbol
PMEPA1
Additional TMEPAI Products
Product Documents for TMEPAI Antibody (rPMEPA1/6422) [DyLight 550]
Product Specific Notices for TMEPAI Antibody (rPMEPA1/6422) [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...